zanubrutinib Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (2)

Phase 1/2 (1)
Phase 2 (1)

Interventional (2)

BeiGene (1)
Institute of Hematology & Blood Diseases Hospital (1)

No (2)

No (2)

Adult (18+) (2)

I am/have/had

I am/have/hadcancer, hepatocellular

I am/have/hadsystemic therapy

I am/have/hadfever

I am/have/hadcarcinoma

I am/have/hadmantle cell lymphoma

I am/have/hadsolid tumour

I am/have/hadesophageal cancer

I am/have/hadmsi-h

I am/have/hadnon-small cell lung cancer

I am/have/hadtreatment regimen

I am/have/hadb-cell lymphoma

I am/have/hadsolid tumors

I am/have/hadremission

I am/have/hadcancer of the ovary

I am/have/hadcryoglobulinemia

I am/have/hadrenal cell carcinoma

I am/have/hadchronic lymphocytic leukemia

I am/have/hadneutrophil count

I am/have/hadcancer, ovarian

I am/have/hadindolent lymphoma

added new label for I am/have/had

more

I am looking for

I am looking forixazomib

I am looking forchlorambucil

I am looking fordexamethasone

I am looking formelanoma

I am looking forcyclophosphamide

I am looking forzanubrutinib

I am looking forfludarabine

I am looking fortislelizumab

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Oncology
Recruiting

Zanubrutinib Ixazomib and Dexamethasone in Patients With Treatment Naive Waldenstrom's Macroglobulinemia

We propose this combination will improve the deep remission (VGPR) compared to single Zanubrutinib or IRD regimen and can be a time-limited regimen which will reduce the life-time therapy and benefit the patients.

fever

lymphoma

ixazomib

cold agglutinin

treatment regimen

0 views
19 Feb, 2024

Phase 1
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Family Medicine
Recruiting

Brief Title: Study of BGB-10188 as Monotherapy and in Combination With Zanubrutinib and Tislelizumab

The purpose of this study is to determine the maximum tolerated dose (MTD), recommended Phase 2 dose(RP2D),safety & tolerability of BGB-10188: as monotherapy in participants with mature B-cell malignancies; oin combination with zanubrutinib in participants with relapse/refractory follicular lymphoma (R/R FL), mantle cell lymphoma (MCL) or diffuse large B-cell lymphoma …

cancer, hepatocellular

systemic therapy

carcinoma

mantle cell lymphoma

solid tumour

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.